Furthermore, a case of PE associated with CA in a patient with cirrhosis and thrombocytopenia (high risk of bleeding) was reported, in which a total dose of 12 mg of tPA was administered, resulting in symptomatic improvement and no evidence of residual thrombus on follow-up ETT [35]. This evidence concerns the gene PLAT and Thrombocytopenia.